Global Insulin Delivery Device Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Type (Insulin Pen, Insulin Syringe, Insulin Pump and Others)

  • ID: 3382587
  • Report
  • Region: Global
  • 87 Pages
  • P&S Market Research
1 of 6
The global insulin delivery devices market, worth $9,499.1 million in 2014, is expected to grow at a CAGR of 7.0% during 2015-2020

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Animas Corporation
  • B. Braun Melsungen AG
  • Eli Lilly and Company
  • Insulet Corporation
  • Medtronic, Inc.
  • MORE
The global insulin delivery device market accounted for revenues of $9,998.3 million in 2015, and it is expected to grow at a CAGR of 6.6% during 2016-2022. Based on type, the insulin pump segment is expected to witness the fastest growth during the forecast period, at a CAGR of 7.2% globally.

Diabetes is a chronic disease caused due to insufficient production or inappropriate use of insulin in the body. Proper intervention is needed for diabetes, so as to reduce complications, such as damage of kidney, eyes, heart and feet, and death. Insulin in delivered with the help of various delivery devices such as insulin pumps, pen injectors, insulin syringe and jet injectors. Insulin syringes are most commonly used delivery system for self-medication. However, insulin syringe not being a convenient option resulted in development of other devices for the treatment of diabetes.

The global insulin delivery device market is growing at a significant rate, due to growing geriatric population, increasing prevalence of diabetes and increasing prevalence of obesity. In addition, the technological advancement in the delivery device and increasing awareness of diabetic care are also driving the growth of the global market. The increasing awareness of diabetes across the globe through campaigns, conferences and activities is creating awareness about the long term effects and complications of diabetes and encourages people to enter regular diabetes checkups. The restraints associated with the growth of the global insulin delivery device market include hazards and risks associated with delivery device and high analogue cost.

Geographically, North America is expected to maintain its dominance in the global market of insulin delivery device during 2016-2022. This is due to increasing prevalence of diabetes, growing geriatric population, and increasing prevalence of obesity in the region. In addition, the technological advancement in the delivery device is also driving the growth of the North American market.

The European insulin delivery device market is growing, mainly due to growing aging population, increasing prevalence of diabetes, and increasing awareness of diabetic care. However, the Asia-Pacific market of insulin delivery device is expected to witness the highest growth globally, during the forecast period. This is due to the growing geriatric population and surge in diabetes and obesity. Additionally, the large population pool and increasing awareness of diabetic care are driving the growth of the market in the region.

Some of the key companies operating in the global insulin delivery device market include Novo Nordisk A/S, Medtronic PLC, Abbott Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi S.A., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Animas Corporation, B. Braun Melsungen AG, and Ypsomed Holdings AG.
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Animas Corporation
  • B. Braun Melsungen AG
  • Eli Lilly and Company
  • Insulet Corporation
  • Medtronic, Inc.
  • MORE
1. Research Scope and Methodology
1.1 Market Definition
1.2 Market Scope
1.2.1 Global insulin delivery device market breakdown by type
1.2.2 Global insulin delivery device market breakdown by geography
1.3 Research Methodology and Sources

2. Executive Summary
2.1 Key Findings
2.2 Research Summary

3. Market Outlook
3.1 Introduction
3.2 Trends in the Global Insulin Delivery Device Market
3.2.1 Home infusion therapy achieving significance in the treatment of diabetes treatment
3.2.2 Artificial pancreas gaining popularity in the insulin delivery device market
3.3 Factors Driving Growth of the Market and its Impact on Market Forecast
3.3.1 Increasing prevalence of diabetes
3.3.2 Growing geriatric population
3.3.3 Increasing prevalence of obesity
3.3.4 Technological advancement in drug delivery device
3.3.5 Increasing awareness about diabetic care
3.3.6 Impact analysis of drivers on market forecast
3.4 Factors Hindering the Growth of the Market and its Impact on Market Forecast
3.4.1 Hazards and risks associated with drug delivery device
3.4.2 High insulin analogue cost
3.4.3 Impact analysis of restraints on market forecast

4. Global Insulin Delivery Device Market Size and Forecast (2012 – 2022)
4.1 Global Insulin Delivery Device Market, by Type
4.2 Global Insulin Delivery Device Market, by Region

5. Global Insulin Delivery Device Market, by Type
5.1 Insulin Syringe Market
5.2 Insulin Pump Market
5.3 Insulin Pen Market

6. Global Insulin Delivery Device Market, by Geography
6.1 North America Insulin Delivery Device Market
6.1.1 North America insulin delivery device market, by type
6.1.2 North America insulin delivery device market, by country
6.1.2.1 U.S. insulin delivery device market
6.1.2.1.1 U.S. insulin delivery device market, by type
6.1.2.2 Canada insulin delivery device market
6.1.2.2.1 Canada insulin delivery device market, by type
6.2 Europe Insulin Delivery Device Market
6.2.1 Europe insulin delivery device market, by type
6.2.2 Europe insulin delivery device market, by country
6.2.2.1 Germany insulin delivery device market
6.2.2.1.1 Germany insulin delivery device market, by type
6.2.2.2 U.K. insulin delivery device market
6.2.2.2.1 U.K. insulin delivery device market, by type
6.2.2.3 France insulin delivery device market
6.2.2.3.1 France insulin delivery device market, by type
6.2.2.4 Italy insulin delivery device market
6.2.2.4.1 Italy insulin delivery device market, by type
6.2.2.5 Spain insulin delivery device market
6.2.2.5.1 Spain insulin delivery device market, by type
6.3 Asia-Pacific Insulin Delivery Device Market
6.3.1 Asia-Pacific insulin delivery device market, by type
6.3.2 Asia-Pacific insulin delivery device market, by country
6.3.2.1 Japan insulin delivery device market
6.3.2.1.1 Japan insulin delivery device market, by type
6.3.2.2 China insulin delivery device market
6.3.2.2.1 China insulin delivery device market, by type
6.3.2.3 India insulin delivery device market
6.3.2.3.1 India insulin delivery device market, by type
6.4 Rest of the World (RoW) Insulin Delivery Device Market
6.4.1 RoW insulin delivery device market, by type

7. Competitive Analysis
7.1 Porter’s Five Forces of Competitive Position Analysis
7.1.1 Bargaining power of buyers
7.1.2 Bargaining power of suppliers
7.1.3 Threat of new entrants
7.1.4 Intensity of rivalry
7.1.5 Threat of substitutes
7.2 Competitive Positioning of the Insulin Delivery Device Market, by Type

8. Company Profiles and Strategic Developments
8.1 Key Company Profiles
8.1.1 Medtronic PLC
8.1.1.1 Business overview
8.1.1.2 Product and service offerings
8.1.2 Insulet Corporation
8.1.2.1 Business overview
8.1.2.2 Product and service offerings
8.1.3 Abbott Laboratories
8.1.3.1 Business overview
8.1.3.2 Product and service offerings
8.1.4 Novo Nordisk A/S
8.1.4.1 Business overview
8.1.4.2 Product and service offerings
8.1.5 Eli Lilly and Company
8.1.5.1 Business overview
8.1.5.2 Product and service offerings
8.1.6 Sanofi S.A.
8.1.6.1 Business overview
8.1.6.2 Product and service offerings
8.1.7 Becton, Dickinson and Company
8.1.7.1 Business overview
8.1.7.2 Product and service offerings
8.1.8 B. Braun Melsungen AG
8.1.8.1 Business overview
8.1.8.2 Product and service offerings
8.1.9 Animas Corporation
8.1.9.1 Business overview
8.1.9.2 Product and service offerings
8.1.10 Ypsomed Holding AG
8.1.10.1 Business overview
8.1.10.2 Products and services
8.1.11 F. Hoffmann-La Roche Ltd
8.1.11.1 Business overview
8.1.11.2 Product and service offerings
8.2 Strategic Developments in the Insulin Delivery Device Market
8.2.1 Product approval and launch
8.2.2 Merger and Acquisition
8.2.3 Partnership and Collaboration
8.2.4 Other developments

9. Appendix
9.1 List of Abbreviations

LIST OF TABLES

TABLE 1 SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION
TABLE 2 GLOBAL INSULIN DELIVERY DEVICE MARKET SNAPSHOT
TABLE 3 COMPARISON OF VARIOUS INSULIN DELIVERY DEVICES
TABLE 4 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 5 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 6 GLOBAL INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 7 GLOBAL INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 8 GLOBAL INSULIN DELIVERY DEVICE MARKET, BY REGION, $M (2012 – 2015)
TABLE 9 GLOBAL INSULIN DELIVERY DEVICE MARKET, BY REGION, $M (2016 – 2022)
TABLE 10 GLOBAL INSULIN SYRINGE MARKET, BY REGION, $M (2012 – 2015)
TABLE 11 GLOBAL INSULIN SYRINGE MARKET, BY REGION, $M (2016 – 2022)
TABLE 12 GLOBAL INSULIN PUMP MARKET, BY REGION, $M (2012 – 2015)
TABLE 13 GLOBAL INSULIN PUMP MARKET, BY REGION, $M (2016 – 2022)
TABLE 14 GLOBAL INSULIN PEN MARKET, BY REGION, $M (2012 – 2015)
TABLE 15 GLOBAL INSULIN PEN MARKET, BY REGION, $M (2016 – 2022)
TABLE 16 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 17 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 18 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2012 – 2015)
TABLE 19 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2016 – 2022)
TABLE 20 U.S. INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 21 U.S. INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 22 CANADA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 23 CANADA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 24 EUROPE INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 25 EUROPE INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 26 EUROPE INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2012 – 2015)
TABLE 27 EUROPE INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2016 – 2022)
TABLE 28 GERMANY INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 29 GERMANY INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 30 U.K. INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 31 U.K. INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 32 FRANCE INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 33 FRANCE INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 34 ITALY INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 35 ITALY INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 36 SPAIN INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 37 SPAIN INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 38 ASIA-PACIFIC INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 39 ASIA-PACIFIC INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 40 ASIA-PACIFIC INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2012 – 2015)
TABLE 41 ASIA-PACIFIC INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2016 – 2022)
TABLE 42 JAPAN INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 43 JAPAN INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 44 CHINA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 45 CHINA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 46 INDIA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 47 INDIA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 48 ROW INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2015)
TABLE 49 ROW INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2016 – 2022)
TABLE 50 MEDTRONIC PLC – KEY FACTS
TABLE 51 INSULET CORPORATION – KEY FACTS
TABLE 52 ABBOTT LABORATORIES – KEY FACTS
TABLE 53 NOVO NORDISK A/S– KEY FACTS
TABLE 54 ELI LILLY AND COMPANY – KEY FACTS
TABLE 55 SANOFI S.A. – KEY FACTS
TABLE 56 BECTON, DICKINSON AND COMPANY – KEY FACTS
TABLE 57 B. BRAUN MELSUNGEN AG – KEY FACTS
TABLE 58 ANIMAS CORPORATION – KEY FACTS
TABLE 59 YPSOMED HOLDING AG – KEY FACTS
TABLE 60 F. HOFFMANN-LA ROCHE LTD – KEY FACTS

LIST OF FIGURES

FIG 1 MARKET SCOPE FOR GLOBAL INSULIN DELIVERY DEVICE MARKET
FIG 2 RESEARCH METHODOLOGY FOR GLOBAL INSULIN DELIVERY DEVICE MARKET
FIG 3 GLOBAL DIABETIC POPULATION, AGED 20-79 YEARS (2013)
FIG 4 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION, IN MAJOR COUNTRIES
FIG 5 GLOBAL PREVALENCE OF OBESITY IN DIFFERENT REGIONS, %
FIG 6 GLOBAL INSULIN DELIVERY DEVICE MARKET, $M (2012 – 2022)
FIG 7 GLOBAL INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 8 GLOBAL INSULIN DELIVERY DEVICE MARKET SHARE, BY TYPE (2015 AND 2022)
FIG 9 GLOBAL INSULIN DELIVERY DEVICE MARKET, BY REGION, $M (2012 – 2022)
FIG 10 GLOBAL INSULIN DELIVERY DEVICE MARKET SHARE, BY REGION (2015 AND 2022)
FIG 11 GLOBAL INSULIN SYRINGE MARKET, BY REGION, $M (2012 – 2022)
FIG 12 GLOBAL INSULIN PUMP MARKET, BY REGION, $M (2012 – 2022)
FIG 13 GLOBAL INSULIN PEN MARKET, BY REGION, $M (2012 – 2022)
FIG 14 INSULIN DELIVERY DEVICE MARKET SIZE IN MAJOR COUNTRIES (2022)
FIG 15 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 16 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2012 – 2022)
FIG 17 U.S. INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 18 CANADA INSULIN DELIVERY DEVICE MARKET , BY TYPE, $M (2012 – 2022)
FIG 19 EUROPE INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 20 EUROPE INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2012 – 2022)
FIG 21 GERMANY INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 22 U.K. INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 23 FRANCE INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 24 ITALY INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 25 SPAIN INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 26 ASIA-PACIFIC INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 27 ASIA-PACIFIC INSULIN DELIVERY DEVICE MARKET, BY COUNTRY, $M (2012 – 2022)
FIG 28 JAPAN INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 29 CHINA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 30 INDIA INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 31 ROW INSULIN DELIVERY DEVICE MARKET, BY TYPE, $M (2012 – 2022)
FIG 32 PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS
FIG 33 COMPETITIVE POSITIONING OF THE INSULIN DELIVERY DEVICE MARKET, BY TYPE
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Animas Corporation
  • B. Braun Melsungen AG
  • Eli Lilly and Company
  • Insulet Corporation
  • Medtronic, Inc.
  • MORE
his research offers actual historical market size (2011 - 2014) and forecast market size (2015 - 2020) of the global insulin delivery devices market in the U.S. dollars.

Global Insulin Delivery Devices Market:

- By Type - Insulin Syringes, Insulin Pumps, Insulin Pen, Insulin Jet Injectors and Others
- By Region - North America, Europe, Asia and Rest of World

Global Insulin Delivery Devices Market, by Type:

- Insulin syringes market breakdown by region
- Insulin pump market breakdown by region
- Insulin pen market breakdown by region
- Insulin jet injectors market breakdown by region
- Others market breakdown by region

Global Insulin Delivery Devices Market, by Geography:

North America Insulin Delivery Devices Market

North America insulin delivery devices market breakdown by country - The U.S., Canada, and Rest of North America
- The U.S. insulin delivery devices market
- - By type
- Canada insulin delivery devices market
- - By type

Europe Insulin Delivery Device Market

Europe insulin delivery devices market breakdown by country - Germany, the U.K., France, Italy, Spain, and Rest of Europe
- Germany insulin delivery devices market
- - By type
- The U.K. insulin delivery devices market
- - By type
- France insulin delivery devices market
- - By type
- Italy insulin delivery devices market
- - By type
- Spain insulin delivery devices market
- - By type

Asia Insulin Delivery Devices Market

Asia-Pacific insulin delivery devices market breakdown by country - China, Japan, India and Rest of Asia
- China insulin delivery devices market
- - By type
- Japan insulin delivery devices market
- - By type
- India insulin delivery devices market
- - By type

Rest of the World Insulin Delivery Devices Market

- Rest of the World (RoW) insulin delivery devices market breakdown
- By type

Note: Product cover images may vary from those shown
5 of 6
- Abbott Laboratories, Inc.
- Animas Corporation
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Eli Lilly and Company
- F. Hoffmann-La Roche, Ltd.
- Insulet Corporation
- Medtronic, Inc.
- Novo Nordisk A/S
- Sanofi
- Ypsomed Holdings AG

Note: Product cover images may vary from those shown
6 of 6
Question How has the market been segmented in this report?
Answer The analytsts have segmented the market on the basis of the type of delivery devices such as insulin pump, insulin pen, insulin jet injectors and insulin syringe
Note: Product cover images may vary from those shown
Adroll
adroll